Clinical Trial Update: Patient Reported Outcomes in Adults With Severe Eosinophilic Asthma on Benralizumab.

View source ↗

Summary

This clinical trial update reports patient-reported outcomes from a completed study of benralizumab in adults with severe eosinophilic asthma, focusing on quali…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Asthma

Drugs mentioned

• FASENRA (BENRALIZUMAB)

Snippet

Sponsor: AstraZeneca | Conditions: Severe Eosinophilic Asthma | Status: COMPLETED